Relationship Between Inflammation, Insulin Resistance and Type 2 Diabetes: 'Cause or Effect'?

Greenfield, Jerry R.; Campbell, Lesley V.
June 2006
Current Diabetes Reviews;2006, Vol. 2 Issue 2, p195
Academic Journal
Inflammation has been implicated as an important aetiological factor in the development of both insulin resistance and type 2 diabetes mellitus. This conclusion is predominantly drawn from studies demonstrating associations between elevated (but 'normal range') levels of circulating acute phase inflammatory markers, typified by C-reactive protein (CRP), and indices of insulin resistance and the development of type 2 diabetes. There is debate as to whether these associations are independent of body fatness or, rather, an epiphenomenon of obesity, particularly central obesity, a strong predictor of insulin resistance and type 2 diabetes and an important source of inflammatory cytokines, such as interleukin-6. Some of this controversy and the inability to draw definitive conclusions from these studies relate to the fact that most studies measure body fat and its distribution indirectly using anthropometric estimates, such as Body Mass Index and waist circumference, rather than directly by dual-energy X-ray absorptiometry, computed tomography or magnetic resonance imaging. Furthermore, use of the term inflammation may be inappropriate when describing mild elevations of CRP in the 'normal range' in the absence of the other changes that characterise classical inflammatory diseases, such as a reduction in levels (or evidence of consumption) of complement proteins. Debate as to whether obesity mediates the association between circulating levels of inflammatory markers and insulin resistance can be resolved by well-designed studies using body fat measured by gold-standard methods. In this review, we present evidence to support the suggestion that body fat is the primary determinant of circulating inflammatory marker levels in the basal state and that marginally elevated levels of circulating interleukin-6 and CRP in obesity are a consequence rather than a cause of insulin resistance. The importance of genetic influences in determining both body fatness and circulating CRP levels will also be discussed. The review will conclude with a discussion of possible mechanisms linking body fat and insulin resistance to elevated circulating levels of inflammatory markers, including the possible role of the toll-like family of immune receptors.


Related Articles

  • Pharmacological and non-pharmacological interventions to influence adipose tissue function. Westerink, Jan; Visseren, Frank L. J. // Cardiovascular Diabetology;2011, Vol. 10 Issue 1, p13 

    Obesity is associated with metabolic derangements such as insulin resistance, inflammation and hypercoagulobility which can all be understood as consequences of adipose tissue dysfunction. The potential role for adipose tissue derived cytokines and adipokines in the development of vascular...

  • STAT4 Deficiency Reduces Obesity-Induced Insulin Resistance and Adipose Tissue Inflammation. Dobrian, Anca D.; Galkina, Elena V.; Ma, Qian; Hatcher, Margaret; Aye, Sabai Myo; Butcher, Mathew J.; Ma, Kaiwen; Haynes, Bronson A.; Kaplan, Mark H.; Nadler, Jerry L. // Diabetes;Dec2013, Vol. 62 Issue 12, p4109 

    Signal transducer and activator of transcription (STAT) 4 is one of the seven members of the STAT family. STAT4 has a prominent role in mediating interleukin-12-induced T-helper cell type 1 lineage differentiation. T cells are key players in the maintenance of adipose tissue (AT) inflammation....

  • Combined Neural Inactivation of Suppressor of Cytokine Signaling-3 and Protein-Tyrosine Phosphatase-1B Reveals Additive, Synergistic, and Factor-Specific Roles in the Regulation of Body Energy Balance. Briancon, Nadege; McNay, David E.; Maratos-Flier, Eleftheria; Flier, Jeffrey S. // Diabetes;Dec2010, Vol. 59 Issue 12, p3074 

    OBJECTIVE--The adipokine hormone leptin triggers signals in the brain that ultimately lead to decreased feeding and increased energy expenditure. However, obesity is most often associated with elevated plasma leptin levels and leptin resistance. Suppressor of cytokine signaling (SOCS)-3 and...

  • Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus. Zilverschoon, G R C; Tack, C J; Joosten, L A B; Kullberg, B J; van der Meer, J W M; Netea, M G // International Journal of Obesity;Sep2008, Vol. 32 Issue 9, p1407 

    Objective:Interleukin-18 (IL-18) has been recently demonstrated to improve experimental hyperphagia and insulin resistance. Paradoxically, concentrations of circulating IL-18 in obese subjects and in patients with type 2 diabetes are increased. The objective of this study is to provide an...

  • Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients. Rieusset, Jennifer; Bouzakri, Karim; Chevillotte, Emmanuel; Ricard, Nadège; Jacquet, Delphine; Bastard, Jean-Philippe; Laville, Martine; Vidal, Hubert; Ricard, Nadège // Diabetes;Sep2004, Vol. 53 Issue 9, p2232 

    Interleukin-6 (IL-6) could be a possible mediator of insulin resistance. We investigated whether IL-6 could inhibit insulin signaling in human skeletal myotubes and whether suppressor of cytokine signaling 3 (SOCS-3) could be related to insulin resistance in vivo in humans. IL-6 inhibited...

  • Inflammatory cytokines adiponectin, resistin, IL-6 and IFN-γ are associated with insulin resistance in eutrophic and obese children. Klünder-Klünder, Miguel; Cruz, Miguel; García-Macedo, Rebeca; Flores-Huerta, Samuel // Boletin Medico del Hospital Infantil de Mexico (Elsevier Science;ene/feb2014, Vol. 71 Issue 1, p8 

    Background: Obesity, a worldwide health problem, is associated with the increase of noncommunicable diseases. Excess adipose tissue above what is expected produces a cytokine imbalance decreasing adiponectin—an anti-inflammatory cytokine—and increasing those proinfl ammatory...

  • How Inflammation Impinges on NAFLD: A Role for Kupffer Cells. Duarte, Nádia; Coelho, Inês C.; Patarrão, Rita S.; Almeida, Joana I.; Penha-Gonçalves, Carlos; Macedo, M. Paula // BioMed Research International;5/18/2015, Vol. 2015, p1 

    Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming the most prevalent cause of liver disease worldwide and afflicts adults and children as currently associated with obesity and insulin resistance. Even though lately some advances have been made to elucidate the mechanism and causes of...

  • Adipokines and Risk of Type 2 Diabetes in Older Men. Wannamethee, S. Goya; Lowe, Gordon D. O.; Rumley, Ann; Cherry, Lynne; Whincup, Peter H.; Sattar, Naveed // Diabetes Care;May2007, Vol. 30 Issue 5, p1200 

    OBJECTIVE -- The aim was to assess the relationship between adipokines, including interleukin (IL)-6, leptin, and adiponectin, with development of type 2 diabetes and assess the role of obesity and insulin resistance in these relationships. RESEARCH DESIGN AND METHODS -- We conducted a...

  • Lipocalin-2 Deficiency Attenuates Insulin Resistance Associated With Aging and Obesity. Law, Ivy K. M.; Xu, Aimin; Lam, Karen S. L.; Berger, Thorsten; Mak, Tak W.; Vanhoutte, Paul M.; Liu, Jacky T. C.; Sweeney, Gary; Zhou, Mingyan; Yang, Bo; Wang, Yu // Diabetes;Apr2010, Vol. 59 Issue 4, p872 

    OBJECTIVE--The proinflammatory cytokines/adipokines produced from adipose tissue act in an autocrine and/or endocrine manner to perpetuate local inflammation and to induce peripheral insulin resistance. The present study investigates whether lipocalin-2 deficiency or replenishment with this...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics